Home
Conditions
Non-Muscle Invasive Bladder Neoplasms

Clinical trial condition

Non-Muscle Invasive Bladder Neoplasms

Explore clinical trials studying Non-Muscle Invasive Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

209 public trials 72 recruiting studies

Refine in advanced search Browse all conditions

Non-Muscle Invasive Bladder Neoplasms trial results

Recruiting

Effects of Microbiological and Immunological Factors on the Lower Urinary Tract

NCT07494864

Conditions: Acute Catheter-associated UTI (CAUTI), Asymptomatic Bacteriuria in Subjects Not Requiring Assisted Bladder Emptying, Asymptomatic Bacteriuria in Subjects Relying on Some Type of Catheter, +20 more
Locations: Balgrist University Hospital Zurich, Canton of Zurich, Switzerland

View Trial Details

Recruiting

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

NCT06800963

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Arizona Clinical Trials Chandler, Arizona, United States

Golden State Urology Sacramento, California, United States

Emory University Atlanta, Georgia, United States

Michigan Institute of Urology & Solaris Health Troy, Michigan, United States

View Trial Details

Recruiting

Early vs Delayed Intravesical Blad-Care During BCG Therapy

NCT07495072

Conditions: BCG-Induced Cystitis, Carcinoma, Cystitis, +15 more
Locations: Kyung Hee University Hospital Seoul, Dongdaemun-gu, South Korea

View Trial Details

Recruiting

Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer

NCT07474519

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

NCT06173349

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Recruiting

The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer

NCT07130578

Conditions: Bladder Cancer, Carcinoma, Female Urogenital Diseases, +14 more
Locations: General Hospital of Tianjin Medical University Tianjin, China

The second hospital of Tianjin Medical University Tianjin, China

View Trial Details

Recruiting

Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study

NCT07339761

Conditions: Bladder Cancer, Carcinoma, Female Urogenital Diseases, +15 more
Locations: Department of Urology, Aarhus University Hospital Aarhus, Denmark

View Trial Details

Recruiting

Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)

NCT05962541

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations: AOU Policlinico Umberto I Hospital, UOC Urologia SMUC05, Rome, Italy Rome, Lazio, Italy

View Trial Details

Recruiting

Blue Light Cystoscopy With Cysview® Registry

NCT02660645

Conditions: Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
Locations: The University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Clinic Phoenix, Arizona, United States

USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

University of California Los Angeles Los Angeles, California, United States

View all 23 locations

View Trial Details

Recruiting

A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer

NCT05327647

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: London Health Sciences Centre London, Ontario, Canada

University Health Network, Princess Margaret Cancer Centre Toronto, Ontario, Canada

Centre intégré de santé et services sociaux de Chaudière Appalaches Lévis, Quebec, Canada

Centre Hospitalier de l'Université De Montréal_CHUM Montreal, Quebec, Canada

View Trial Details

Non-Muscle Invasive Bladder Neoplasms

Non-Muscle Invasive Bladder Neoplasms trial results

Related conditions